CIK 0001468492 · <br>Emerging growth company
HeartSciences Inc.
Sign in to watch- Ticker
- HSCS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Apr 30
- Incorporated
- TX
- Entity type
- operating
- EIN
- 261344466
- Phone
- 682-237-7781
- Business address
- 550 RESERVE ST, SUITE 360, SOUTHLAKE, TX, 76092
- Former names
- Heart Test Laboratories, Inc.
Securities
- HSCS Common Stock Nasdaq
- HSCSW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-16 | Watson Danielle See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2025-01-16 | Szymczak Brian Director | Grant or award · Employee Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2025-01-16 | Simpson Andrew See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-08-12 | Simpson Andrew See Remarks | Other acquisition | +17 | 7,629 | ||
| 2023-03-20 | Simpson Andrew See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2023-03-20 | Szymczak Brian Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-20 | Wells David R. Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-20 | Bent Bruce Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-20 | HILZ MARK T See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2023-03-20 | Watson Danielle See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 2 of 2 · 30 trades